Core Viewpoint - BGM Group Ltd. and Jointown Pharmaceutical Group have strengthened their strategic partnership through a recent meeting, culminating in a signed cooperation agreement for licorice-based products, which is expected to enhance their collaboration in the pharmaceutical sector [1][5][6] Company Overview - BGM Group Ltd. is an innovative company based in Chengdu, China, focusing on biopharmaceuticals, bio-extraction, and medical health, with products including oxytetracycline APIs, licorice preparations, and crude heparin sodium [8] - Jointown Pharmaceutical Group is a leading enterprise in China's pharmaceutical industry, specializing in Western medicine, traditional Chinese medicine, and medical devices, with a vast sales network [2] Partnership Dynamics - The partnership between BGM Group and Jointown is characterized by high synergy in product research, development, production, and sales, leveraging BGM's R&D capabilities and Jointown's extensive sales network [3] - Both companies share a commitment to quality control and customer service excellence, ensuring product safety and consumer satisfaction [3] Strategic Cooperation Agreement - The signed strategic cooperation agreement focuses on licorice fluid extract and Gandixin (Compound Licorice Tablets), marking a significant milestone in their collaboration [5] - The agreement is expected to inject strong momentum into their future development in the pharmaceutical industry [5] Market Trends and Future Outlook - The meeting highlighted discussions on market demand for high-quality pharmaceutical products, indicating a growing consumer preference for efficiency and quality in the industry [4] - Both companies are dedicated to driving product innovation and quality improvement to meet diverse market needs [4]
BGM Group and Jointown Deepen Cooperation, Ushering in a New Era of Pharmaceutical Development